The future role for oral exfoliative cytology - Bleak or bright?

European Journal of Cancer Part B: Oral Oncology

Volumn 33, Issue 1, 1997, Pages 2-4

  Ogden, G R ^a  

^a DUNDEE DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

Exfoliative cytology; Oral; Oral cancer; Screening

Indexed keywords

TUMOR MARKER;

CYTOLOGY; EXFOLIATIVE CYTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MOUTH CANCER; PRIORITY JOURNAL; REVIEW;

GENES, P53; GENETIC MARKERS; HUMANS; MOUTH NEOPLASMS; MUTATION;

EID: 0030957557     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-1955(96)00047-4     Document Type: Review

References (50)

1. 1. Boyle, P., Macfarlane, G. J., Maisonneuve, P., Zheng, T., Scully, C. and Tedesco, B., Epidemiology of mouth cancer in 1989: a review. Journal of the Royal Society of Medicine, 1990, 80, 724-730.
2. 2. Shah, J. P. and Lydiatt, W., Treatment of cancer of the head and neck. CA-Cancer J Clin, 1995, 45, 352-368.
3. 3. Stell, P. M. and McCormick, M. S., Cancer of the head and neck: are we doing any better? Lancet, 1985, ii, 1127.
4. 4. Tanaka, T., Chemoprevention of oral carcinogenesis. Oral Oncology, European Journal of Cancer, 1995, 31B, 3-15.
5. 5. Stell, P. M., Wood, G. D. and Scott, M. H., Early oral cancer: treatment by biopsy excision. British Journal of Oral Surgery, 1982, 20, 234-236.
6. 6. Scully, C., Malamos, D., Levers, B. G. H., Porter, S. R. and Prime, S. S., Sources and patterns of referrals of oral cancer: role of general practitioners. British Medical Journal, 1986, 293, 599-601.
7. 7. Ogden, G. R., Cowpe, J. G. and Chisholm, D. M., Cost of oral screening. Lancet, 1991, 337, 920-921.
8. 8. Guggenheimer, J, Verbin, R. S., Johnson, J. T., Horkowitz, C. A. and Myers, E. N., Factors delaying the diagnosis of oral and oropharygeal carcinomas. Cancer, 1989, 64, 932-935.
9. 9. Cooke, B. E. D. and Tapper-Jones, L., Recognition of oral cancer, causes of delay. British Dental Journal, 1977, 142, 96-98.
10. 10. Mashberg, A. and Samit, A. M., Early detection, diagnosis and management of oral and oropharyngeal cancer. CA-Cancer J Clin, 1989, 39, 67-88.
11. 11. Cowpe, J. G., Longmore, R. B. and Green, M. W., Quantitative exfoliative cytology of abnormal oral mucosal smears. Journal of The Royal Society of Medicine, 1988, 81, 509-513.
12. 12. Ogden, G. R. and Cowpe, J. G., Quantitative cytophotometric analysis as an aid to the detection of recurrent oral cancer. British Journal of Oral Maxillofacial Surgery, 1989, 27, 224-228.
13. 13. UICC. In Manual of Clinical Oncology, 4th edn, ed. C. D. Sherman. Springer, Geneva, 1987.
14. 14. Katz, H. C., Shear, M. and Altini, M., A critical evaluation of epithelial dysplasia in oral mucosal lesions using the Smith-Pindborg method of standardisation. Journal of Oral Pathology, 1985, 14, 476-482.
15. 15. Pindborg, J. J., Reibel, J. and Holmstrup, P., Subjectivity of evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. Journal of Oral Pathology, 1985, 14, 698-708.
16. 16. Frame, J. W., The management of oral premalignant lesions. British Journal of Oral Maxillofacial Surgery, 1992, 30, 71.
17. 17. Ogden, G. R., Cowpe, J. G. and Green, M. W., Quantitative exfoliative cytology of normal buccal mucosa: effect of smoking. Journal of Oral Pathology and Medicine, 1990, 19, 53-55.
18. 18. Ogden, G. R., Cowpe, J. G. and Green, M. W., Detection of field change in oral cancer using oral exfoliative cytologic study. Cancer, 1991, 68, 1611-1615.
19. 19. Wight, A., Sivarajasingam, V., Rice, P., Cowpe, J. and Ogden, G., Quantitative cytology of buccal mucosal cells: effect of alcohol. Journal of Dental Research, 1995, 74, 880.
20. 20. Cowpe, J. G., Longmore, R. B. and Green, M. W., Quantitative exfoliative cytology of normal oral squames: An age, site and sex related survey. Journal of The Royal Society of Medicine, 1985, 78, 995-1004.
21. 21. Ogden, G. R., McQueen, S., Chisholm, D. M. and Lane, E. B., Keratin profiles of normal and malignant oral mucosa using exfoliative cytology. Journal of Clinical Pathology, 1993, 46, 352-356.
22. 22. Bongers, V., Snow, G. B., Vries, N. de and Braakhuis, B. J. M., Potential early markers of carcinogenesis in the mucosa of the head and neck using exfoliative cytology. Journal of Pathology, 1996, 178, 284-289.
23. 23. Franzen, G., Klintenberg, C., Olofsson, J. and Risberg, B., DNA measurement: An objective predictor of response to irradiation? A review of 24 squamous cell carcinomas of the oral cavity. British Journal of Cancer, 1986, 53, 643-651.
24. 24. Tytor, M., Franzen, G., Olofsson, J., Brunk, U. and Nordenskjold, B., DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas. British Journal of Cancer, 1987, 56, 647-652.
25. 25. Lane, E. B. and Alexander, C. M., Use of keratin antibodies in tumour diagnosis. Seminar of Cancer Biology, 1990, 1, 165-179.
26. 26. Ogden, G. R., Leigh, I., Chisholm, D. M., Cowpe, J. G. Lane, E. B., Exfoliative cytology of normal oral mucosa-assessing basal cell keratin phenotype. Acta Cytologica, 1996, 40, 933-936.
27. 27. Ogden, G. R., Chisholm, D. M., Adi, M. and Lane, E. B., Cytokeratin expression in oral cancer and its relationship to tumour differentiation. Journal of Oral Pathology and Medicine, 1993, 22, 82-86.
28. 28. Ogden, G. R., Cowpe, J. G., Chisholm, D. M. and Lane, E. B., DNA and keratin analysis of oral exfoliative cytology in the detection of oral cancer. Oral Oncology, European Journal of Cancer, 1994, 30B, 405-408.
29. 29. Ogden, G. R., Cowpe, J. G., Chisholm, D. M. and Lane, D. P., p53 immunostaining as a marker for oral cancer in diagnostic cytopathology - preliminary report. Cytopathology, 1994, 5, 47-53.
30. 30. Hall, P. A. and Lane, D. P., p53 in tumour pathology: Can we trust immunohistochemistry? Revisited! Journal of Pathology, 1994, 172, 1-4.
31. 31. Bartek, J., Bartkova, J., Vojtesek, B., et al., Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene, 1991, 6, 1699-1703.
32. 32. Sauter, E. R., Cleveland, D., Trock, B., Ridge, J. A. and Slein-Szanto, A. J. P., p53 is overexpressed in fifty percent of preinvasive lesions of head and neck epithelium. Carcinogenesis, 1994, 15, 2269-2274.
33. 33. Ahomadegbe, J. C., Barrois, M., Fogel, S., et al., High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene, 1995, 10, 1217-1227.
34. 34. Ogden, G. R., Lane, D. P. and Chisholm, D. M., p53 expression in dyskeratosis congenita: a marker for oral premalignancy? Journal of Clinical Pathology, 1993, 46, 169-170.
35. 35. Brennan, J. A., Mao, L., Hruban, R. H., et al., Molecular assessment of histopathological staging in squamous-cell carcnoma of the head and neck. New England Journal of Medicine, 1995, 332, 429-435.
36. 36. Bowes, G., Sivarajasingam, V., Chisholm, D., Rice, P. and Ogden, G. R., Cell sampling from whole saliva: reproducibility and influence of alcohol abuse. Journal of Dental Research, 1995, 74, 880.
37. 37. Hagerman, R. J., Wilson, P., Staley, L. W., et al., Evaluation of school children at high risk for fragile X syndrome utilizing buccal cell FMR-1 testing. American Journal of Medicine and Genetics, 1994, 51, 474-481.
38. 38. Field, J. K., Kiaris, H., Risk, J. M., et al., Allelotype of squamous cell carcinoma of the head and neck; fractional allele loss correlates with survival. British Journal of Cancer, 1995, 72, 1180-1188.
39. 39. Chen, R. H. and Fuggle, S. V., In situ cDNA polymerase chain reaction: research and clinical applications. In Progress in Pathology:, Vol. 2, ed. N. Kirkham and N. R. Lemoine. Churchill Livingstone, Edinburgh, 1995, pp. 211-225.
40. 40. Riva, C., Lavieille, J.-P., Reyt, E., Brambilla, E., Lunardi, J. and Brambilla, C., Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance. Oral Oncology, European Journal of Cancer, 1995, 31B, 384-391.
41. 41. Wilson, G. D., Richman, P. I., Dische, S, et al., p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy. British Journal of Cancer, 1995, 71, 1248-1252.
42. 42. Lattime, E. C. and Gerson, S. L., Introduction: Genes, oncogenes, and gene therapy. Strategies for cancer. Seminar Oncology, 1996, 23, 1-3.
43. 43. Merlano, M., Benasso, M., Cavallari, M., Blengio, F. and Rosso, M., Chemotherapy in head and neck cancer. Oral Oncology, European Journal of Cancer, 1994, 30B, 283-289.
44. 44. Boyle, P., Chiesa, F. and Scully, C., Chemoprevention and oral cancer - (More) trials and (More) tribulations. Oral Oncology, European Journal of Cancer, 1995, 31B, 1-2.
45. 45. Zakrzewska, J., Hindle, I. and Speight, P. M., Practical considerations in the establishment of an oral screening programme. Community Dental Health, Vol. 10, Suppl. 1, 1993, 79-85.
46. 46. Boyle, P., Macfarlane, G. J., Blot, W. J., et al., European School of Oncology, advisory report to the European Commission for the Europe Against Cancer programme: oral carcinogenesis in Europe. Oral Oncology, European Journal of Cancer, 1995, 31B, 75-85.
47. 47. Scully, C., Clinical diagnostic methods for the detection of premalignant and early malignant oral lesions. In Screening for Oral Cancer and Precancer. Report of a U.K. Working Group, ed. P. M. Speight, M. C. Downer and I. Zakrzewska, 1993, 10, 43-52.
48. 48. Tucker, J. H., Cowpe, J. G. and Ogden, G. R., Nuclear DNA content and morphometric characteristics of normal, premalignant and malignant oral smears. Analytical Cell Pathology, 1994, 6, 117-128.
49. 49. Dabelsteen, E., Roed-Petersen, B., Smith, C. J. and Pindborg, J. J., The limitations of exfoliative cytology for the detection of epithelial atypia in oral leukoplakias. British Journal of Cancer, 1971, 25, 21-24.
50. 50. Scully, C. and Field, J. K., Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN), with reference to oral carcinoma (Review). International Journal of Oncology, 1977, 10, 5-21.